Evidence map›Paper›PMID 11090513›Full record

ArticleBMJ (Clinical research ed.)2000

Priority setting for new technologies in medicine: qualitative case study.

P A Singer, D K Martin, M Giacomini, L Purdy

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ethics education and moral decision-making in clinical commissioning: an interview study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

P A SingerUniversity of Toronto Joint Centre for Bioethics, Toronto, ON, Canada M5G 1L4. peter.singer@utoronto.ca
D K Martin
M Giacomini
L Purdy

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe priority setting for new technologies in medicine.

designQualitative study using case studies and grounded theory.

settingTwo committees advising on priorities for new technologies in cancer and cardiac care in Ontario, Canada.

participantsThe two committees and their 26 members.

main outcome measuresAccounts of priority setting decision making gathered by reviewing documents, interviewing members, and observing meetings.

resultsSix interrelated domains were identified for priority setting for new technologies in medicine: the institutions in which the decision are made, the people who make the decisions, the factors they consider, the reasons for the decisions, the process of decision making, and the appeals mechanism for challenging the decisions.

conclusionThese domains constitute a model of priority setting for new technologies in medicine. The next step will be to harmonise this description of how priority setting decisions are made with ethical accounts of how they should be made.

Indexed as

Costs and Cost AnalysisDecision Making, OrganizationalEmpirical ResearchHealth ExpendituresHealth PolicyHealth PrioritiesHeart DiseasesHumansNeoplasmsOntarioOrganizational Case StudiesProfessional Staff CommitteesQualitative ResearchTechnology Assessment, BiomedicalEmpirical ApproachHealth Care and Public Health

Identifiers

PMID11090513
PMCPMC27534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.